What one share of Edgewise Therapeutics holds
At Edgewise, we appreciate the life-limiting impact of serious muscle diseases. Our science-driven culture places patients first as we start with their unmet needs and then work towards developing therapies to help address the significant challenges of serious muscle diseases.
Edgewise Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.85 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$1.49 |
| Cash and investments | $0.67 |
| Book value | $4.16 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | — | −$23.17 | $0.27 | −$20.08 | — | −$33.11 |
| 2021 | — | −$1.14 | $0.02 | −$0.91 | — | $5.54 |
| 2022 | — | −$1.26 | $0.10 | −$1.09 | — | $5.48 |
| 2023 | — | −$1.57 | $0.09 | −$1.53 | — | $4.53 |
| 2024 | — | −$1.45 | $0.01 | −$1.19 | — | $4.84 |
| 2025 | — | −$1.63 | $0.00 | −$1.40 | — | $4.92 |
Common questions about Edgewise Therapeutics
How much does one share of Edgewise Therapeutics earn?
Over the last 12 months, Edgewise Therapeutics lost $1.85 for each share.
Does Edgewise Therapeutics pay a dividend?
Edgewise Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Edgewise Therapeutics’s book value per share?
Edgewise Therapeutics’s book value is $4.16 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Edgewise Therapeutics have?
Each share of Edgewise Therapeutics has $0.67 of cash and investments, as of June 30, 2026.
What is Edgewise Therapeutics’s free cash flow per share?
−$1.49 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Edgewise Therapeutics bought back shares?
Edgewise Therapeutics’s share count rose about 13828% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.